Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6383136 | 7135603 | I | 6383136-8 | 20090907 | 20090930 | EXP | CA-GENENTECH-291154 | GNEFDAAERSPRD | M | Y | 20090930 | OT | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6383136 | 1012357329 | PS | NUTROPIN AQ | 1 | SUBCUTANEOUS | 0.75 MG, 1/WEEK X 6 | NOT REPORTED | 020522 | |||
| 6383136 | 1012357330 | C | ADDERALL 10 | 1 | |||||||
| 6383136 | 1012357331 | C | MELATONIN | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6383136 | 1012357329 | GROWTH HORMONE DEFICIENCY |
| 6383136 | 1012357330 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
| 6383136 | 1012357331 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6383136 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6383136 | NEOPLASM RECURRENCE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6383136 | 1012357329 | 20080826 | 20090801 |